As of 2024-12-12, the EV/EBITDA ratio of MacroGenics Inc (MGNX) is -0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGNX's latest enterprise value is 34.39 mil USD. MGNX's TTM EBITDA according to its financial statements is -89.10 mil USD. Dividing these 2 quantities gives us the above MGNX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 19.4x | 17.2x |
| Forward P/E multiples | 15.8x - 29.8x | 22.4x |
| Fair Price | (19.51) - (24.65) | (25.21) |
| Upside | -672.2% - -822.9% | -839.3% |
| Date | EV/EBITDA |
| 2024-12-11 | -0.39 |
| 2024-12-10 | -0.34 |
| 2024-12-09 | -0.44 |
| 2024-12-06 | -0.45 |
| 2024-12-05 | -0.37 |
| 2024-12-04 | -0.44 |
| 2024-12-03 | -0.41 |
| 2024-12-02 | -0.58 |
| 2024-11-29 | -0.51 |
| 2024-11-27 | -0.55 |
| 2024-11-26 | -0.38 |
| 2024-11-25 | -0.30 |
| 2024-11-22 | -0.27 |
| 2024-11-21 | -0.25 |
| 2024-11-20 | -0.29 |
| 2024-11-19 | -0.44 |
| 2024-11-18 | -0.46 |
| 2024-11-15 | -0.50 |
| 2024-11-14 | -0.67 |
| 2024-11-13 | -0.64 |
| 2024-11-12 | -0.87 |
| 2024-11-11 | -1.08 |
| 2024-11-08 | -1.05 |
| 2024-11-07 | -1.13 |
| 2024-11-06 | -0.94 |
| 2024-11-05 | -0.64 |
| 2024-11-04 | -0.59 |
| 2024-11-01 | -0.71 |
| 2024-10-31 | -0.56 |
| 2024-10-30 | -0.38 |
| 2024-10-29 | -0.34 |
| 2024-10-28 | -0.46 |
| 2024-10-25 | -0.44 |
| 2024-10-24 | -0.52 |
| 2024-10-23 | -0.76 |
| 2024-10-22 | -0.73 |
| 2024-10-21 | -0.70 |
| 2024-10-18 | -0.81 |
| 2024-10-17 | -0.82 |
| 2024-10-16 | -0.89 |
| 2024-10-15 | -0.79 |
| 2024-10-14 | -1.00 |
| 2024-10-11 | -0.90 |
| 2024-10-10 | -0.62 |
| 2024-10-09 | -0.56 |
| 2024-10-08 | -0.53 |
| 2024-10-07 | -0.51 |
| 2024-10-04 | -0.51 |
| 2024-10-03 | -0.48 |
| 2024-10-02 | -0.47 |